Insiders · PCSA

PCSA insider transactions

Processa Pharmaceuticals Inc. (PCSA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for PCSA

• 6h
  Pres. Research & Development Young David bought $4,589 worth of shares (2,067 units at $2.22), increasing direct ownership by 12% to 19,198 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 6h
  Chief Financial Officer Skibsted Russell bought $5,892 worth of shares (2,654 units at $2.22), increasing direct ownership by 25% to 13,412 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 6h
  Chief Executive Officer Ng George K bought $5,472 worth of shares (2,465 units at $2.22), increasing direct ownership by 25% to 12,435 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 6h
  Chief Business - Strategy Off Lin Patrick bought $4,065 worth of shares (1,831 units at $2.22), increasing direct ownership by 20% to 11,007 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 6h
  Chief Administrative Officer Guy Wendy bought $4,702 worth of shares (2,118 units at $2.22), increasing direct ownership by 22% to 11,958 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 15d
  Pres. Research & Development Young David bought $4,590 worth of shares (1,786 units at $2.57), increasing direct ownership by 12% to 17,131 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 15d
  Chief Financial Officer Skibsted Russell bought $5,890 worth of shares (2,292 units at $2.57), increasing direct ownership by 27% to 10,758 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 15d
  Chief Executive Officer Ng George K bought $5,472 worth of shares (2,129 units at $2.57), increasing direct ownership by 27% to 9,970 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 15d
  Chief Business - Strategy Off Lin Patrick bought $4,066 worth of shares (1,582 units at $2.57), increasing direct ownership by 21% to 9,176 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 15d
  Chief Administrative Officer Guy Wendy bought $4,701 worth of shares (1,829 units at $2.57), increasing direct ownership by 23% to 9,840 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 28d
  Chief Executive Officer Ng George K bought $5,474 worth of shares (1,843 units at $2.97), increasing direct ownership by 31% to 7,841 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 28d
  Pres. Research & Development Young David bought $4,589 worth of shares (1,545 units at $2.97), increasing direct ownership by 11% to 15,345 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 28d
  Chief Business - Strategy Off Lin Patrick bought $4,066 worth of shares (1,369 units at $2.97), increasing direct ownership by 22% to 7,594 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 28d
  Chief Administrative Officer Guy Wendy bought $4,702 worth of shares (1,583 units at $2.97), increasing direct ownership by 25% to 8,011 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 28d
  Chief Financial Officer Skibsted Russell bought $5,892 worth of shares (1,984 units at $2.97), increasing direct ownership by 31% to 8,466 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 28d
  Amendment: Chief Executive Officer Ng George K bought $5,474 worth of shares (1,843 units at $2.97), increasing direct ownership by 86% to 3,979 units (SEC Form 4)

  4/A - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 28d
  Amendment: Chief Development Officer Bigora Sian bought $5,341 worth of shares (1,971 units at $2.71), increasing direct ownership by 36% to 7,481 units (SEC Form 4)

  4/A - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 46d
  Pres. Research & Development Young David bought $4,589 worth of shares (1,706 units at $2.69), increasing direct ownership by 14% to 13,813 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 46d
  Chief Financial Officer Skibsted Russell bought $5,891 worth of shares (2,190 units at $2.69), increasing direct ownership by 51% to 6,498 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 46d
  Chief Executive Officer Ng George K bought $5,471 worth of shares (2,034 units at $2.69), increasing direct ownership by 51% to 6,013 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 46d
  Chief Business - Strategy Off Lin Patrick bought $4,065 worth of shares (1,511 units at $2.69), increasing direct ownership by 32% to 6,236 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 46d
  Chief Administrative Officer Guy Wendy bought $4,702 worth of shares (1,748 units at $2.69), increasing direct ownership by 37% to 6,441 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 46d
  Chief Development Officer Bigora Sian bought $5,342 worth of shares (1,986 units at $2.69), increasing direct ownership by 36% to 7,496 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 47d
  Amendment: Chief Executive Officer Ng George K bought $5,415 worth of shares (2,136 units at $2.54) (SEC Form 4)

  4/A - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 47d
  Amendment: Chief Executive Officer Ng George K bought $5,474 worth of shares (1,843 units at $2.97), increasing direct ownership by 86% to 3,979 units (SEC Form 4)

  4/A - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 60d
  SEC Form 4 filed by Young David

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 60d
  SEC Form 4 filed by Ng George K

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 60d
  SEC Form 4 filed by Lin Patrick

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 60d
  SEC Form 4 filed by Guy Wendy

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 60d
  SEC Form 4 filed by Bigora Sian

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 60d
  SEC Form 4 filed by Skibsted Russell

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 75d
  SEC Form 4 filed by Neal James R

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 76d
  SEC Form 4 filed by Young David

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 76d
  SEC Form 4 filed by Skibsted Russell

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 76d
  SEC Form 4 filed by Pannu Geraldine

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 76d
  SEC Form 4 filed by Ng George K

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 76d
  SEC Form 4 filed by Lin Patrick

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 76d
  SEC Form 4 filed by Guy Wendy

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 76d
  SEC Form 4 filed by Bigora Sian

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 76d
  SEC Form 4 filed by Baluch Khoso

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 132d
  Pres. Research & Development Young David converted options into 49 shares, increasing direct ownership by 0.56% to 8,752 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 132d
  Chief Business - Strategy Off Lin Patrick converted options into 193 shares, increasing direct ownership by 12% to 1,753 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 132d
  Chief Administrative Officer Guy Wendy converted options into 193 shares, increasing direct ownership by 18% to 1,256 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 132d
  Chief Development Officer Bigora Sian converted options into 249 shares, increasing direct ownership by 18% to 1,604 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 256d
  SEC Form 4 filed by Director Neal James R

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 256d
  SEC Form 4 filed by Director Baluch Khoso

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 256d
  SEC Form 4 filed by Director Pannu Geraldine

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 256d
  SEC Form 4 filed by Director Yorke Justin W

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 256d
  SEC Form 4 filed by Chief Administrative Officer Guy Wendy

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 256d
  SEC Form 4 filed by Chief Business - Strategy Off Lin Patrick

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 256d
  SEC Form 4 filed by Chief Development Officer Bigora Sian

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 256d
  SEC Form 4 filed by Chief Financial Officer Skibsted Russell

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 256d
  SEC Form 4 filed by Pres. Research & Development Young David

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 256d
  SEC Form 4 filed by Chief Executive Officer Ng George K

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 271d
  Amendment: SEC Form 4 filed by Chief Administrative Officer Guy Wendy

  4/A - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 271d
  Amendment: SEC Form 4 filed by Director Yorke Justin W

  4/A - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 271d
  Amendment: SEC Form 4 filed by Pres. Research & Development Young David

  4/A - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 271d
  Amendment: SEC Form 4 filed by Chief Financial Officer Skibsted Russell

  4/A - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 271d
  Amendment: SEC Form 4 filed by Director Pannu Geraldine

  4/A - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 271d
  Amendment: SEC Form 4 filed by Chief Executive Officer Ng George K

  4/A - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)